Returning to Boston for the 2nd year, the Macrophage-directed Therapies Summit is the only industry-focused meeting dedicated to advancing current CD47 and CAR-macrophage therapies alongside the new and exciting macrophage targets being identified and studied.
Join this exclusive macrophage community to network and learn from the leading experts in pharma, biotech and academia, as we discuss how to successfully and safely harness the clinical benefit of macrophages for oncological indications and beyond.
Navigate across 3 days packed with dedicated, interactive formats exploring the clinical development of CD47 checkpoint blockades, combination strategies, macrophage repolarization approaches and engineered macrophages.
“This meeting is increasingly becoming the venue for significant breaking news in the field"
Past Attendee from the Cell & Viral Immunotherapy Series, Tmunity Therapeutics
“This summit is an ideal size and attracts the key players in the field. Good opportunity for networking and getting the relevant updates about progress in the space."
Past Attendee from the Cell & Viral Immunotherapy Series, GSK